Dexcom Schedules Fourth Quarter and Fiscal Year 2024 Earnings Release and Conference Call for February 13, 2025 at 4:30 p.m. Eastern Time.
DexCom (NASDAQ:DXCM) has announced its plans to release its fourth quarter and fiscal year 2024 financial results after market close on Thursday, February 13, 2025. The company will host a conference call at 4:30 p.m. Eastern Time on the same day to review the performance.
Investors can access the conference call by dialing (888) 414-4585 (US/Canada) or (646) 960-0331 (International) using the confirmation ID '9430114'. A concurrent webcast will be available on the Dexcom investor relations website at investors.dexcom.com, where it will also be archived for future reference.
DexCom (NASDAQ:DXCM) ha annunciato i suoi piani per rilasciare i risultati finanziari del quarto trimestre e dell'anno fiscale 2024 dopo la chiusura del mercato giovedì 13 febbraio 2025. L'azienda ospiterà una conference call alle 16:30 ora orientale dello stesso giorno per esaminare le performance.
Gli investitori possono partecipare alla conference call componendo il numero (888) 414-4585 (US/Canada) o (646) 960-0331 (Internazionale) utilizzando l'ID di conferma '9430114'. Un webcast contemporaneo sarà disponibile sul sito web delle relazioni con gli investitori di Dexcom su investors.dexcom.com, dove sarà anche archiviato per riferimenti futuri.
DexCom (NASDAQ:DXCM) ha anunciado sus planes de publicar sus resultados financieros del cuarto trimestre y del año fiscal 2024 después del cierre del mercado el jueves 13 de febrero de 2025. La empresa llevará a cabo una llamada de conferencia a las 4:30 p.m. hora del este el mismo día para revisar el desempeño.
Los inversores pueden acceder a la llamada de conferencia marcando (888) 414-4585 (EE. UU./Canadá) o (646) 960-0331 (Internacional) usando la ID de confirmación '9430114'. También habrá una transmisión en vivo disponible en el sitio web de relaciones con inversores de Dexcom en investors.dexcom.com, donde también se archivará para futuras referencias.
DexCom (NASDAQ:DXCM)은 2025년 2월 13일 목요일 시장 마감 후 2024년 4분기 및 회계연도 재무 결과를 발표할 계획이라고 발표했습니다. 회사는 같은 날 동부 표준시 오후 4시 30분에 성과를 검토하기 위한 컨퍼런스 콜을 개최할 예정입니다.
투자자는 확인 ID '9430114'를 사용하여 (888) 414-4585(US/Canada) 또는 (646) 960-0331(International)로 전화하여 컨퍼런스 콜에 접속할 수 있습니다. Dexcom 투자자 관계 웹사이트인 investors.dexcom.com에서 동시 웹캐스트를 이용할 수 있으며, 여기서도 향후 참조를 위해 보관됩니다.
DexCom (NASDAQ:DXCM) a annoncé son intention de publier ses résultats financiers pour le quatrième trimestre et l'exercice 2024 après la clôture des marchés, le jeudi 13 février 2025. L'entreprise organisera une conférence téléphonique le même jour à 16h30, heure de l'Est, pour examiner les performances.
Les investisseurs peuvent participer à la conférence téléphonique en composant le (888) 414-4585 (États-Unis/Canada) ou le (646) 960-0331 (International) à l'aide de l'ID de confirmation '9430114'. Un webinaire en direct sera également disponible sur le site des relations investisseurs de Dexcom à investors.dexcom.com, où il sera archivé pour référence future.
DexCom (NASDAQ:DXCM) hat seine Pläne bekannt gegeben, die Finanzergebnisse für das vierte Quartal und das Geschäftsjahr 2024 nach Marktschluss am Donnerstag, den 13. Februar 2025, zu veröffentlichen. Das Unternehmen wird am selben Tag um 16:30 Uhr Eastern Time eine Telefonkonferenz abhalten, um die Leistung zu überprüfen.
Investoren können an der Telefonkonferenz teilnehmen, indem sie (888) 414-4585 (USA/Kanada) oder (646) 960-0331 (international) wählen und die Bestätigungs-ID '9430114' verwenden. Ein gleichzeitiger Webcast wird auf der Investor-Relations-Website von Dexcom unter investors.dexcom.com verfügbar sein, wo er auch für zukünftige Referenzen archiviert wird.
- None.
- None.
To listen to the conference call, please dial (888) 414-4585 (US/
About DexCom, Inc.
Dexcom empowers people to take control of health through innovative biosensing technology. Founded in 1999, Dexcom has pioneered and set the standard in glucose biosensing for more than 25 years. Its technology has transformed how people manage diabetes and track their glucose, helping them feel more in control and live more confidently.
Dexcom. Discover what you’re made of. For more information, visit www.dexcom.com.
Category: IR
View source version on businesswire.com: https://www.businesswire.com/news/home/20250130188254/en/
DexCom, Inc.:
Sean Christensen
Vice President – Finance and Investor Relations
investor-relations@dexcom.com
(858) 200-0200
Source: DexCom, Inc.
FAQ
When will Dexcom (DXCM) release Q4 and FY 2024 earnings?
What time is Dexcom's (DXCM) Q4 2024 earnings call?
How can investors access Dexcom's (DXCM) Q4 2024 earnings call?
Where can I find the replay of Dexcom's (DXCM) Q4 2024 earnings call?
